Small renal masses (SRMs) are renal tumors less than 4 cm in diameter. These account for the largest proportion of newly diagnosed renal cell cancers (RCC). Management of SRMs can be a dilemma if the patient is unfit to undergo partial nephrectomy. Molecular profiling enables better characterization of RCC and prediction of outcomes in terms of recurrence and progression. This article reviews the existing literature on molecular profiling of localized RCC, discusses limitations of molecular profiling, and presents the likely role that molecular profiling will play in guiding the treatment of SRMs
In recent years molecular biologists and pathologists have described new entities of renal cell canc...
This chapter reviews the current literature in view of varying clinical practices surrounding the di...
It is well known that renal cell carcinoma (RCC) has a relatively low incidence, accounting for 3 % ...
Small renal masses (SRMs) represent a heterogeneous group showing a variety of clinical and biologic...
Objective: To review the natural history and growth kinetics of small renal masses (SRMs). Data Sou...
Renal cell carcinoma (RCC) constitutes an array of morphologically and genetically distinct tumors w...
This thesis addresses a number of current topics in the diagnosis and treatment of Localized Renal C...
Abstract Among the adult population, renal cell carcinoma (RCC) constitutes the most p...
International audiencePURPOSE: We characterized the clinicopathological features and the prognosis o...
Small renal masses (SRM) are defined as contrast-enhancing solid masses detected on diagnostic imagi...
The diffusion of imaging has determined an increased discovery of small renal masses (SRMs). Recent ...
The incidence of renal cell carcinoma (RCC) is increasing and outcomes remain poor. One-third of pat...
Introduction: The incidence of benign lesions is more common in small renal masses (SRMs) and biolog...
Renal cell carcinoma (RCC) is the most common form of kidney cancer in adults. RCC is a significant ...
<p>Standard treatment of renal neoplasms remains surgical resection, and nephrectomy for localised r...
In recent years molecular biologists and pathologists have described new entities of renal cell canc...
This chapter reviews the current literature in view of varying clinical practices surrounding the di...
It is well known that renal cell carcinoma (RCC) has a relatively low incidence, accounting for 3 % ...
Small renal masses (SRMs) represent a heterogeneous group showing a variety of clinical and biologic...
Objective: To review the natural history and growth kinetics of small renal masses (SRMs). Data Sou...
Renal cell carcinoma (RCC) constitutes an array of morphologically and genetically distinct tumors w...
This thesis addresses a number of current topics in the diagnosis and treatment of Localized Renal C...
Abstract Among the adult population, renal cell carcinoma (RCC) constitutes the most p...
International audiencePURPOSE: We characterized the clinicopathological features and the prognosis o...
Small renal masses (SRM) are defined as contrast-enhancing solid masses detected on diagnostic imagi...
The diffusion of imaging has determined an increased discovery of small renal masses (SRMs). Recent ...
The incidence of renal cell carcinoma (RCC) is increasing and outcomes remain poor. One-third of pat...
Introduction: The incidence of benign lesions is more common in small renal masses (SRMs) and biolog...
Renal cell carcinoma (RCC) is the most common form of kidney cancer in adults. RCC is a significant ...
<p>Standard treatment of renal neoplasms remains surgical resection, and nephrectomy for localised r...
In recent years molecular biologists and pathologists have described new entities of renal cell canc...
This chapter reviews the current literature in view of varying clinical practices surrounding the di...
It is well known that renal cell carcinoma (RCC) has a relatively low incidence, accounting for 3 % ...